» Articles » PMID: 29288062

The Degree of Leukoaraiosis Predicts Clinical Outcomes and Prognosis in Patients with Middle Cerebral Artery Occlusion After Intravenous Thrombolysis

Overview
Journal Brain Res
Specialty Neurology
Date 2017 Dec 31
PMID 29288062
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Leukoaraiosis (LA) is common in elderly patients with ischemic stroke on magnetic resonance imaging. In this study, we investigate whether the degree of LA is associated with clinical outcomes and prognosis of patients with middle cerebral artery occlusion following intravenous thrombolytic. Ninety-seven patients were recruited and divided into three groups based on the degree of LA (no, mild and moderate to severe LA) by the Fazekas scale. Clinical outcomes, recurrent stroke, Fugl-Meyer rating scale (FMS) and complications of intravenous thrombolysis were assessed. The association between the degree of LA and functional outcomes was analyzed by multivariable logistic regression model. Patients enrolled were divided into three groups: 26 patients with no LA, 43 patients with mild LA and 28 patients with moderate to severe LA. Impressively, the patients with mild LA were better in early neurological recovery and 90-day FMS score than patients in the other two groups. Multivariate logistic analysis revealed that moderate to severe LA was an independent predictor of poor functional outcome (OR: 10.482; 95% CI: 1.442-76.181; P = .020). Moreover, the patients with moderate to severe LA have a higher rate of hemorrhagic transformation and recurrent stroke as compared with two other groups during 90-day follow-up. Different degrees of LA differentially affect clinical outcome and prognosis in patients with middle cerebral artery occlusion following intravenous thrombolytic. Moderate to severe LA is a risk factor of poor prognosis. Mild LA is associated with early neurological recovery and good motor functional outcome.

Citing Articles

The association between the severity and distribution of white matter lesions and hemorrhagic transformation after ischemic stroke: A systematic review and meta-analysis.

Wang Y, Bai X, Ye C, Yu Y, Wu B Front Aging Neurosci. 2022; 14:1053149.

PMID: 36506465 PMC: 9732368. DOI: 10.3389/fnagi.2022.1053149.


Elucidating the Role of Baseline Leukoaraiosis on Forecasting Clinical Outcome of Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy.

Karatzetzou S, Tsiptsios D, Sousanidou A, Christidi F, Psatha E, Chatzaki M Neurol Int. 2022; 14(4):923-942.

PMID: 36412696 PMC: 9680372. DOI: 10.3390/neurolint14040074.


FLAIR and ADC Image-Based Radiomics Features as Predictive Biomarkers of Unfavorable Outcome in Patients With Acute Ischemic Stroke.

Quan G, Ban R, Ren J, Liu Y, Wang W, Dai S Front Neurosci. 2021; 15:730879.

PMID: 34602971 PMC: 8483716. DOI: 10.3389/fnins.2021.730879.


Neuroimaging Markers of Cerebral Small Vessel Disease on Hemorrhagic Transformation and Functional Outcome After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Wang Y, Yan X, Zhan J, Zhang P, Zhang G, Ge S Front Aging Neurosci. 2021; 13:692942.

PMID: 34326767 PMC: 8315270. DOI: 10.3389/fnagi.2021.692942.


sTWEAK as Predictor of Stroke Recurrence in Ischemic Stroke Patients Treated With Reperfusion Therapies.

Hervella P, Perez-Mato M, Rodriguez-Yanez M, Lopez-Dequidt I, Pumar J, Sobrino T Front Neurol. 2021; 12:652867.

PMID: 34046003 PMC: 8144448. DOI: 10.3389/fneur.2021.652867.